Skip to content


  • Research article
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study

  • Ralf Gold1Email author,
  • Ernst-Wilhelm Radue2,
  • Gavin Giovannoni3,
  • Krzysztof Selmaj4,
  • Eva Havrdova5,
  • Dusan Stefoski6,
  • Till Sprenger2, 7,
  • Xavier Montalban8,
  • Stanley Cohan9,
  • Kimberly Umans10,
  • Steven J. Greenberg11,
  • Gulden Ozen10 and
  • Jacob Elkins10
BMC NeurologyBMC series – open, inclusive and trusted201616:117

Received: 25 October 2015

Accepted: 12 July 2016

Published: 26 July 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting

Original Submission
25 Oct 2015 Submitted Original manuscript
4 Feb 2016 Reviewed Reviewer Report - Lekha Pandit
10 Feb 2016 Reviewed Reviewer Report - Vijayshree Yadav
3 Mar 2016 Reviewed Reviewer Report - Daniel M Harrison
15 Apr 2016 Author responded Author comments - Ralf Gold
Resubmission - Version 2
15 Apr 2016 Submitted Manuscript version 2
22 Jun 2016 Author responded Author comments - Ralf Gold
Resubmission - Version 3
22 Jun 2016 Submitted Manuscript version 3
12 Jul 2016 Editorially accepted
26 Jul 2016 Article published 10.1186/s12883-016-0635-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting

You can find further information about the peer review system here.

Authors’ Affiliations

Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany
Medical Image Analysis Center, University Hospital Basel, Basel, Switzerland
Queen Mary University of London, Blizard Institute, London School of Medicine and Dentistry, London, UK
Medical University of Lodz, Lodz, Poland
First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
Rush University Medical Center, Chicago, USA
DKD Helios Klinik Wiesbaden, Wiesbaden, Germany
Hospital Vall d’Hebron University, Barcelona, Spain
Providence Multiple Sclerosis Center, Portland, USA
Biogen, Cambridge, USA
AbbVie Biotherapeutics Inc., Redwood, USA